Dipna Pharmachem (BOM:543594) Total Liabilities: ₹1,433 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543594 Dipna Pharmachem Ltd BOM:543594
62 GF Score
Price ₹4.89
GF Value ₹9.16
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Dipna Pharmachem Total Liabilities?

Dipna Pharmachem BOM:543594 +9.64% 62 Total Liabilities is ₹1,433 Mil as of Mar. 2026. GuruFocus rates BOM:543594 with a GF Score™ of 62/100 and a GF Value™ of ₹9.16 (Possible Value Trap). The stock has 9 warning signs investors should review.

Dipna Pharmachem's Total Liabilities for the quarter that ended in Mar. 2026 was ₹1,433 Mil.

Dipna Pharmachem's quarterly Total Liabilities increased from Mar. 2025 (₹938.86 Mil) to Sep. 2025 (₹1,185.90 Mil) and increased from Sep. 2025 (₹1,185.90 Mil) to Mar. 2026 (₹1,433.26 Mil).

Dipna Pharmachem's annual Total Liabilities declined from Mar. 2024 (₹953.87 Mil) to Mar. 2025 (₹938.86 Mil) but then increased from Mar. 2025 (₹938.86 Mil) to Mar. 2026 (₹1,433.26 Mil).

Dipna Pharmachem Total Liabilities Historical Data

* Premium members only.

The historical data trend for Dipna Pharmachem's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dipna Pharmachem Total Liabilities Chart

Dipna Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial 344.91 532.02 953.87 938.86 1,433.26

Dipna Pharmachem Semi-Annual Data
Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 953.87 952.61 938.86 1,185.90 1,433.26
BOM:543594
62GF Score
Dipna Pharmachem Ltd BOM:543594
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dipna Pharmachem Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Dipna Pharmachem's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1332.26+(101.001+0.00099999999994793
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1,433

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=2056.294-623.032
=1,433

Dipna Pharmachem's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1332.26+(101.001+0.00099999999994793
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1,433

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=2056.294-623.032
=1,433

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹1,433 Mil mean?
Dipna Pharmachem (BOM:543594) has a Total Liabilities of ₹1,433 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Dipna Pharmachem and its competitors.
Is Dipna Pharmachem's Total Liabilities too high?
Dipna Pharmachem's current Total Liabilities is ₹1,433 Mil. Overall, Dipna Pharmachem has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dipna Pharmachem's Total Liabilities compare to competitors?
Dipna Pharmachem's Total Liabilities of ₹1,433 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Healthcare Providers & Services company?
A good Total Liabilities depends on the Healthcare Providers & Services industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Dipna Pharmachem and its competitors. Dipna Pharmachem's current Total Liabilities is ₹1,433 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dipna Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Dipna Pharmachem (BOM:543594) is currently considered Possible Value Trap. The stock's GF Value™ is ₹9.16, compared to a current price of ₹4.89 — trading 46.6% below its estimated fair value. The current Total Liabilities is ₹1,433 Mil. Dipna Pharmachem's overall GF Score™ is 62/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Dipna Pharmachem (BOM:543594), the current Total Liabilities is ₹1,433 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dipna Pharmachem (BOM:543594) Overvalued in 2026?

Based on GuruFocus' analysis, Dipna Pharmachem stock appears to be undervalued. The current stock price of ₹4.89 is trading 46.6% below its estimated GF Value™ of ₹9.16. GuruFocus considers Dipna Pharmachem to be Possible Value Trap.

Key valuation signals for BOM:543594:

  • Total Liabilities: ₹1,433 Mil
  • GF Value™: ₹9.16 vs. price of ₹4.89 (46.6% below fair value)
  • GF Score™: 62/100 with 9 warning signs

No single metric tells the full story. See the BOM:543594 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dipna Pharmachem Business Description

Address A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380055
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.
62GF Score

Get the complete analysis for BOM:543594

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4.89
Price
₹9.16
GF Value